Gubra looks beyond metabolism, hopes for first portfolio company this year
The Copenhagen-based drugmaker Gubra's present is mostly about obesity. Its future will need to be about a much broader pipeline. The company has a portfolio of weight loss drug candidates but is moving into the ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.